ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership
May 30, 2018Ipsen (Euronext: IPN; ADR: IPSEY), a global biopharmaceutical group, and The University of Texas MD Anderson Cancer Center today announced a global licensing and joint development agreement for a pre-clinical oncology drug candidate discovered by research
Pharma Sources Insight January 2025
